People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AbCellera Biologics Inc. | — | Biotechnology | Series C | $83.0M | $3.1B | 2017 |
| Amphp, Inc. | — | Biotechnology | Series B | $39.1M | $304.8M | 2021 |
| Synaptive Medical Inc. | — | Biotechnology | Series A | $34.8M | $180.5M | 2015 |
| Aequus Pharmaceuticals Inc. | — | Biotechnology | Seed | $1.1M | $20.6M | 2016 |
Doug Janzen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Doug Janzen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chris Clark | 1 | 9 |
| John Hamer | 1 | 7 |
| Peter Rahal | 1 | 6 |
| Hamed Shahbazi | 1 | 6 |
| Michael DeMane | 1 | 4 |
| ANN FEHR | 1 | 4 |
| Michael Hayden | 1 | 4 |
| Andrew Prozes | 1 | 3 |
| Kevin Datoo | 1 | 3 |
| Cameron Piron | 1 | 2 |
| Fotios Plakogiannis | 1 | 2 |
| William Patrick Ryan | 1 | 2 |
| Ian Ball | 1 | 2 |
| Melanie Strong | 1 | 2 |
| Carl Hansen | 1 | 2 |
| Donald McAfee | 1 | 1 |
| Anne Stevens | 1 | 1 |
| Jason Flowerday | 1 | 1 |
| Rodoula Plakogiannis | 1 | 1 |
| Christina Yip | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.